Chen Xin Selected Research

Chen Xin Research Topics

Disease

16	Glaucoma 03/2023 - 05/2008
10	Open-Angle Glaucoma (Glaucoma, Open Angle) 06/2023 - 01/2016
7	Neoplasms (Cancer) 04/2024 - 05/2011
2	Hypoxia (Hypoxemia) 11/2022 - 11/2019
2	Inflammation (Inflammations) 05/2022 - 01/2022
2	Myopia 01/2022 - 03/2021
2	Cataract (Cataracts) 01/2022 - 07/2020
2	Pain (Aches) 01/2022 - 01/2021
2	Neuroblastoma 10/2017 - 02/2013
1	Hematologic Neoplasms (Hematological Malignancy) 04/2024
1	Brain Edema (Cerebral Edema) 12/2023
1	Brain Injuries (Brain Injury) 12/2023
1	Insulin Resistance 08/2023
1	Neuroinflammatory Diseases 01/2023
1	Primitive Neuroectodermal Tumors (PNET) 01/2023
1	Critical Illness (Critically Ill) 12/2022
1	Spinal Cord Injuries (Spinal Cord Injury) 05/2022
1	Low Tension Glaucoma 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Congenital Abnormalities (Deformity) 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Arthrogryposis 01/2021
1	hereditary Xerocytosis 01/2021
1	Malaria 12/2019
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2019
1	Poisoning 05/2019
1	Corneal Edema 12/2018
1	Aggressive Fibromatosis (Desmoid) 05/2018
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 05/2018
1	Fibroma (Fibromatosis) 05/2018
1	Gardner Syndrome 05/2018
1	Ocular Hypertension (Glaucoma, Suspect) 01/2016
1	Breast Neoplasms (Breast Cancer) 04/2015
1	Diabetes Mellitus 04/2015
1	Type 2 Diabetes Mellitus (MODY) 04/2015
1	Papilledema 03/2015
1	Hemorrhage 03/2013
1	Renal Insufficiency (Renal Failure) 03/2013

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2013
4	Retinaldehyde (Retinal)IBA 01/2022 - 01/2016
2	Indicators and Reagents (Reagents)IBA 05/2022 - 12/2019
1	MesothelinIBA 04/2024
1	Interleukin-12 (IL 12)IBA 04/2024
1	Chimeric Antigen ReceptorsIBA 04/2024
1	Bevacizumab (Avastin)FDA Link 12/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 08/2023
1	trichostatin A (A 300)IBA 01/2023
1	lorglumideIBA 01/2023
1	repaglinide (Prandin)FDA Link 01/2023
1	ResveratrolIBA 01/2023
1	Vorinostat FDA Link 01/2023
1	Clomipramine (Anafranil)FDA LinkGeneric 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	LuteolinIBA 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2022
1	Ubiquitin-Specific ProteasesIBA 11/2022
1	Deubiquitinating EnzymesIBA 11/2022
1	CurcuminIBA 05/2022
1	ethanoxyhexamercarbideIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	CytokinesIBA 01/2022
1	Meloxicam (Mobic)FDA LinkGeneric 01/2022
1	Vitamin A (Retinol)FDA LinkGeneric 01/2022
1	Ion Channels (Ion Channel)IBA 01/2021
1	Connexin 43 (Connexin43)IBA 01/2021
1	Bicarbonates (Hydrogen Carbonate)IBA 11/2019
1	ParaquatIBA 05/2019
1	EdaravoneIBA 05/2019
1	Contraceptive Agents (Contraceptives)IBA 05/2018
1	S100 Proteins (S 100 Protein)IBA 05/2018
1	RNA (Ribonucleic Acid)IBA 10/2017
1	Antisense OligonucleotidesIBA 10/2017
1	Insulin-Like PeptidesIBA 04/2015
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 04/2015
1	human ERBB2 proteinIBA 04/2015
1	Insulin ReceptorIBA 04/2015
1	Cysteine (L-Cysteine)FDA Link 02/2013
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 02/2013
1	MetalsIBA 05/2011

Therapy/Procedure

10	Trabeculectomy (Trabeculoplasty) 06/2023 - 01/2016
9	Therapeutics 04/2024 - 05/2011
4	Filtering Surgery 10/2020 - 05/2008
2	Acupuncture Therapy 01/2022 - 01/2020
1	Vagus Nerve Stimulation 01/2023
1	Critical Care (Surgical Intensive Care) 12/2022
1	Cannula 01/2022
1	Decompression 01/2022
1	Immunotherapy 01/2022
1	Laminectomy 01/2022
1	Length of Stay 01/2022
1	Traction 01/2022
1	Refractive Surgical Procedures 07/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Catheters 09/2017
1	Lasers (Laser) 01/2017
1	Telescopes 03/2015
1	Bioprosthesis 03/2013